Free Trial

Omnicell (OMCL) Competitors

Omnicell logo
$29.92 +0.23 (+0.77%)
Closing price 10/15/2025 04:00 PM Eastern
Extended Trading
$30.44 +0.52 (+1.75%)
As of 10/15/2025 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OMCL vs. MASI, AMN, WST, HSTM, MDRX, CRTX, IRTC, HNGE, PRVA, and INSP

Should you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Masimo (MASI), AMN Healthcare Services (AMN), West Pharmaceutical Services (WST), HealthStream (HSTM), Veradigm (MDRX), Cortexyme (CRTX), iRhythm Technologies (IRTC), Hinge Health (HNGE), Privia Health Group (PRVA), and Inspire Medical Systems (INSP).

Omnicell vs. Its Competitors

Omnicell (NASDAQ:OMCL) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

Omnicell has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Omnicell has higher earnings, but lower revenue than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omnicell$1.11B1.24$12.53M$0.5059.84
Masimo$2.09B3.85-$304.90M-$8.52-17.44

97.7% of Omnicell shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.5% of Omnicell shares are owned by company insiders. Comparatively, 9.7% of Masimo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Masimo had 6 more articles in the media than Omnicell. MarketBeat recorded 9 mentions for Masimo and 3 mentions for Omnicell. Masimo's average media sentiment score of 0.76 beat Omnicell's score of 0.62 indicating that Masimo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omnicell
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Masimo
2 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Omnicell currently has a consensus target price of $46.71, suggesting a potential upside of 56.13%. Masimo has a consensus target price of $194.60, suggesting a potential upside of 30.99%. Given Omnicell's higher possible upside, analysts clearly believe Omnicell is more favorable than Masimo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omnicell
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
Masimo
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Omnicell has a net margin of 2.01% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat Omnicell's return on equity.

Company Net Margins Return on Equity Return on Assets
Omnicell2.01% 4.27% 2.44%
Masimo -24.85%26.54%11.49%

Summary

Masimo beats Omnicell on 11 of the 17 factors compared between the two stocks.

Get Omnicell News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMCL vs. The Competition

MetricOmnicellMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.36B$2.29B$6.11B$10.46B
Dividend YieldN/AN/A5.73%4.77%
P/E Ratio59.8441.4785.3627.36
Price / Sales1.2413.54605.35135.57
Price / Cash9.7062.9837.4661.86
Price / Book1.1112.8412.436.81
Net Income$12.53M-$65.79M$3.32B$276.80M
7 Day Performance-3.86%1.52%0.58%0.42%
1 Month Performance-7.43%15.04%10.53%7.86%
1 Year Performance-29.70%38.87%72.99%41.24%

Omnicell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMCL
Omnicell
3.681 of 5 stars
$29.92
+0.8%
$46.71
+56.1%
-29.4%$1.36B$1.11B59.843,670
MASI
Masimo
4.3548 of 5 stars
$148.13
+0.6%
$194.60
+31.4%
+3.2%$8.00B$2.09B26.935,600Analyst Upgrade
AMN
AMN Healthcare Services
4.0107 of 5 stars
$19.83
-3.4%
$23.25
+17.2%
-49.3%$786.80M$2.98B9.732,968Analyst Forecast
WST
West Pharmaceutical Services
4.8746 of 5 stars
$268.21
-1.6%
$321.89
+20.0%
-9.5%$19.60B$2.89B39.1610,600Positive News
Upcoming Earnings
Analyst Forecast
HSTM
HealthStream
4.729 of 5 stars
$27.34
-0.1%
$31.00
+13.4%
-9.8%$810.98M$291.65M40.841,093Upcoming Earnings
MDRX
Veradigm
2.7509 of 5 stars
$4.70
flat
$13.00
+176.6%
-48.9%$508.85M$1.53B0.008,000
CRTX
Cortexyme
N/A$1.65
+0.6%
N/A+151.0%$49.75MN/A-0.5655
IRTC
iRhythm Technologies
1.4907 of 5 stars
$175.74
+0.1%
$172.17
-2.0%
+192.2%$5.64B$591.84M0.002,000Analyst Forecast
HNGE
Hinge Health
N/A$51.90
+1.2%
$57.13
+10.1%
N/A$4.02BN/A0.001,514
PRVA
Privia Health Group
3.5077 of 5 stars
$24.13
+0.2%
$28.58
+18.5%
+43.2%$2.96B$1.74B219.001,140
INSP
Inspire Medical Systems
4.9158 of 5 stars
$76.36
-0.3%
$154.43
+102.2%
-60.3%$2.26B$802.80M33.301,246Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:OMCL) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners